| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C0004358> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C0026896> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C0041485> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C0751339> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C0751340> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C4761103> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33421278_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Neurology Unit, Galliera Hospital, Genoa, Italy.\', \'Institute of Neurology, Fondazione Policlinico Universitario \'A. Gemelli\' IRCCS, Rome, Italy.\', \'Catholic University of the Sacred Heart, Rome, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Assini_Andrea> <https://research.tib.eu/covid-19/entity/Damato_Valentina> <https://research.tib.eu/covid-19/entity/Del_Sette_Massimo> <https://research.tib.eu/covid-19/entity/Evoli_Amelia> <https://research.tib.eu/covid-19/entity/Gandoglia_Ilaria> <https://research.tib.eu/covid-19/entity/Rikani_Klaudio>
?:doi	<https://research.tib.eu/covid-19/entity/10.1111/ene.14721>
?:doi	10.1111/ene.14721
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Case_Reports>
?:journal	European journal of neurology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33421278> <https://research.tib.eu/covid-19/entity/wtpq9qgq>
?:pmid	<https://research.tib.eu/covid-19/entity/33421278>
?:pmid	33421278
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.65
?:rankingScore_hIndex	109
?:title	Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33421278>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33421278>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all